<DOC>
	<DOCNO>NCT01971437</DOCNO>
	<brief_summary>This ethically approve randomise control study look whether Cystodistension ( fill bladder fluid pressure ) provide benefit cystoscopy alone ( look bladder ) woman refractory overactive bladder . Urine sample also assess underlie infect cause OAB use urinalysis , microscopy culture cytokine assay ( In collaboration University Kent ) . We hypothesize Cystodistension therapeutic benefit woman refractory OAB increase prevalence chronic urinary infection raise cytokine woman refractory OAB .</brief_summary>
	<brief_title>Cystoscopy Cystodistension ; Therapeutic Aetiological Aspect Overactive Bladder</brief_title>
	<detailed_description>We aim measure outcomes initially , 6 weels 6months follow-up . 1 . Resolution measure Urgency Perception Scale ( UPS ) . Resolution urgency assess UPS . The number woman Level 3 UPS score ( hold finish task ) compare use Chi square test patient treat cystodistension v non cystodistension arm . 2 . Change quality life status determine quality life questionnaire ismilarly comapred 2 arm study . 3 . Change urinary symptom define Patient 's Perception Intensity Scale . Change uregncy score compare 2 arm study . Secondary Outcome Measure:1 . Prevalence chronic urinary infection organism patient refractory OAB 2 . To identify whether urinary cytokine present high proportion patient OAB . Inclusion Criteria 1 . Women OAB symptoms 2 . Women fail bladder drill anticholinergic agent 3 . Women stop medication due side-effects lack efficacy 4 . Currently receive treatment Exclusion Criteria 1 . Patient co-existing urodynamic stress incontinence 2 . Patients neurological disease 3 . Patients pre-existing voiding dysfunction</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Urinary Incontinence , Urge</mesh_term>
	<criteria>Inclusion Criteria 1 . Women OAB symptoms 2 . Women fail bladder drill anticholinergic agent 3 . Women stop medication due sideeffects lack efficacy 4 . Currently receive treatment Exclusion Criteria 1 . Patients coexist urodynamic stress incontinence 2 . Patients neurological disease 3 . Patients preexist void dysfunction Free flow rate &lt; 5th centile equivalent reduce pressure flow rate OR Postvoid residual volume great 100ml</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Overactive Bladder</keyword>
	<keyword>OAB</keyword>
	<keyword>Cystoscopy</keyword>
	<keyword>Cystodistension</keyword>
	<keyword>UTI</keyword>
	<keyword>Cytokines</keyword>
</DOC>